JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Shares, no par value, of Meridian Bioscience, Inc., an Ohio corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: February 4, 2022
Impactive Capital LP | |||
By: | Impactive Capital LLC | ||
its General Partner | |||
By: | /s/ Xxxxxx Xxxxxx Xxxxx | ||
Name: | Xxxxxx Xxxxxx Xxxxx | ||
Title: | Managing Member |
Impactive Capital LLC | |||
By: |
/s/ Xxxxxx Xxxxxx Xxxxx | ||
Name: | Xxxxxx Xxxxxx Xxxxx | ||
Title: | Managing Member |
/s/ Xxxxxx Xxxxxx Xxxxx | |
Xxxxxx Xxxxxx Xxxxx |
/s/ Xxxxxxxxx Xxxxx | |
Xxxxxxxxx Xxxxx |